Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cell breakthrough benefits horse health
Horses
Scientists have created working nerve cells from horse stem cells for the first time.
Discovery could offer new treatments for neurological conditions

A breakthrough in stem cell research could pave the way for new treatments for neurological conditions in horses. For the first time, Edinburgh scientists have succeeded in creating working nerve cells from horse stem cells.

Researchers from the Roslin Institute say the breakthrough could help horses suffering from neurological conditions such as equine grass sickness (EGS) and conditions similar to motor neurone disease in humans.

EGS affects about 600 horses in the UK each year, causing nerve damage throughout the body. No specific treatments are currently available and the disease is poorly understood. EGS in its most serious form is usually fatal.

Roslin scientists took skin cells from a young horse, turning them into stem cells using a technique developed for human cells. These cells were then used to create nerve cells in the laboratory.

The team tested the functionality of the cells in a test tube, proving they could transmit nerve signals.

Scientists say this discovery provides a powerful new tool for studying horse diseases and testing new drugs.

The study has been published in Stem Cells and Development. Author Dr Xavier Donadeu from the institute explained: "Stem cells hold huge therapeutic potential both for people and animals.

"Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."

Veterinary surgeons all over the world already use stem cell therapies to treat horses for different conditions. However, these therapies use adult stem cells, which are harder to maintain and more restricted in the types of cells they can become.

Mostly used to treat tendon ligament and joint problems, the efficacy of these therapies is not entirely proven.

The study is available online here http://online.liebertpub.com/doi/abs/10.1089/scd.2013.0565.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.